142
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

An Unexpected Finding: Treatment History Associated with the Quality of Life in Chinese Patients with Port-Wine Stains

, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 1969-1975 | Received 30 May 2023, Accepted 18 Jul 2023, Published online: 27 Jul 2023

References

  • Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. 1976;58(2):218–222. doi:10.1542/peds.58.2.218
  • Lanigan SW, Cotterill JA. Psychological disabilities amongst patients with port wine stains. Br J Dermatol. 1989;121(2):209–215. doi:10.1111/j.1365-2133.1989.tb01800.x
  • van der Horst CM, de Borgie CA, Knopper JL, et al. Psychosocial adjustment of children and adults with port wine stains. Br J Plast Surg. 1997;50(6):463–467. doi:10.1016/S0007-1226(97)90335-0
  • Wanitphakdeedecha R, JNC N, Yan C, et al. Quality of life and psychological effects of port-wine stain: a review of literature. Clin Cosmet Investig Dermatol. 2021;14:681–690. doi:10.2147/CCID.S315804
  • Wang J, Zhu YY, Wang ZY, et al. Analysis of quality of life and influencing factors in 197 Chinese patients with port-wine stains. Medicine. 2017;96(51):e9446. doi:10.1097/MD.0000000000009446
  • Hagen SL, Grey KR, Korta DZ, et al. Quality of life in adults with facial port-wine stains. J Am Acad Dermatol. 2017;76(4):695–702. doi:10.1016/j.jaad.2016.10.039
  • Schiffner R, Brunnberg S, Hohenleutner U, et al. Willingness to pay and time trade-off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains. Br J Dermatol. 2002;146(3):440–447. doi:10.1046/j.1365-2133.2002.04613.x
  • Neumann R, Leonhartsberger H, Knobler R, et al. Immunohistochemistry of port-wine stains and normal skin with endothelium-specific antibodies PAL-E, anti-ICAM-1, anti-ELAM-1, and anti-factor VIIIrAg. Arch Dermatol. 1994;130(7):879–883. doi:10.1001/archderm.1994.01690070073011
  • Joseph A, Prasad S, Hynan LS, et al. Differences in quality of life in patients with cutaneous lupus erythematosus with varying income levels. Lupus. 2021;30(6):972–980. doi:10.1177/0961203321999724
  • Bregnhoj A, Thuesen KKH, Emmanuel T, et al. HSP90 inhibitor RGRN-305 for oral treatment of plaque type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study. Br J Dermatol. 2021;186(5):861–874.
  • Vasquez D, Aguirre DC, Sanclemente G. Construct validity and responsiveness of the Colombian version of Skindex-29. Br J Dermatol. 2019;181(4):770–777. doi:10.1111/bjd.17742
  • Xiao Y, Huang X, Jing D, et al. Assessment of the Dermatology Life Quality Index (DLQI) in a homogeneous population under lifetime arsenic exposure. Qual Life Res. 2018;27(12):3209–3215. doi:10.1007/s11136-018-1969-2
  • Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30(2):231–+. doi:10.1016/j.det.2011.11.003
  • Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9(2):169–180. doi:10.1111/j.1087-0024.2004.09113.x
  • Berg M, Lindberg M. Possible gender differences in the quality of life and choice of therapy in acne. J Eur Acad Dermatol Venereol. 2011;25(8):969–972. doi:10.1111/j.1468-3083.2010.03907.x
  • Sampogna F, Chren MM, Melchi CF, et al. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol. 2006;154(2):325–331. doi:10.1111/j.1365-2133.2005.06909.x
  • Sampogna F, Paradisi A, Iemboli ML, et al. Sex differences in health-related quality of life in patients with keratinocyte carcinomas. Acta Derm Venereol. 2021;101(4):adv00439. doi:10.2340/00015555-3736
  • Sawant NS, Vanjari NA, Khopkar U. Gender differences in depression, coping, stigma, and quality of life in patients of vitiligo. Dermatol Res Pract. 2019;2019:6879412. doi:10.1155/2019/6879412
  • Lanigan SW. Port-wine stains unresponsive to pulsed dye laser: explanations and solutions. Br J Dermatol. 1998;139(2):173–177. doi:10.1046/j.1365-2133.1998.02351.x
  • Michel S, Landthaler M, Hohenleutner U. Recurrence of port-wine stains after treatment with the flashlamp-pumped pulsed dye laser. Br J Dermatol. 2000;143(6):1230–1234. doi:10.1046/j.1365-2133.2000.03893.x
  • Hansen K, Kreiter CD, Rosenbaum M, et al. Long-term psychological impact and perceived efficacy of pulsed-dye laser therapy for patients with port-wine stains. Dermatol Surg. 2003;29(1):49–55. doi:10.1046/j.1524-4725.2003.29010.x
  • Fernandez-Penas P, Jones-Caballero M, Espallardo O, et al. Comparison of Skindex-29, dermatology life quality index, psoriasis disability index and medical outcome study short form 36 in patients with mild to severe psoriasis. Br J Dermatol. 2012;166(4):884–887. doi:10.1111/j.1365-2133.2012.10806.x